Other YSPH research includes: Factors that may contribute to risk of non-fatal opioid overdoses The role of mental health, stigma and discrimination in substance use How to integrate behavioral health care for substance use problems into primary care Strategies for limiting the harms of substance use, and more foundational studies of the causes or impacts of inadequately treated substance use or mental illness Using behavioral health economics to develop programs to promote risk-reduction behaviors Potential eHealth applications as effective tools for treating tobacco- and substance-use disorders The economics of substance abuse including lost productivity, cost-effectiveness of treatments, social costs and policy, and drivers behind key disparities The role of substance use in co-morbidities such as cancer and HIV Tobacco and e-cigarette control The impact of the COVID-19 pandemic on prevention for, treatment of, and individual and community harms associated with substance use disorders Recent Publications Latent classes of sleep deficiency and correlates among patients receiving methadone treatment: A longitudinal study.Hsaio C, Jeon S, DiMeola KA, Walker K, Akhiwu O, Stein MD, Madden LM, Redeker NS, Scheinost D, Fiellin DA, Yaggi HK, Barry DT
Glantz MD, Bharat C, Degenhardt L, Sampson NA, Scott KM, Lim CCW, Al-Hamzawi A, Alonso J, Andrade LH, Cardoso G, De Girolamo G, Gureje O, He Y, Hinkov H, Karam EG, Karam G, Kovess-Masfety V, Lasebikan V, Lee S, Levinson D, McGrath J, Medina-Mora M, Mihaescu-Pintia C, Mneimneh Z, Moskalewicz J, Navarro-Mateu F, Posada-Villa J, Rapsey C, Stagnaro JC, Tachimori H, Ten Have M, Tintle N, Torres Y, Williams DR, Ziv Y, Kessler RC
Par consquent, votre niveau d'oxygne sera plus lev
A ban on tobacco marketing
